SG Americas Securities’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Buy |
65,156
+28,976
| +80% | +$463K | ﹤0.01% | 1039 |
|
|
2025
Q1 | $550K | Buy |
36,180
+1,368
| +4% | +$20.8K | ﹤0.01% | 1523 |
|
|
2024
Q4 | $706K | Buy |
34,812
+1,140
| +3% | +$23.1K | ﹤0.01% | 916 |
|
|
2024
Q3 | $866K | Buy |
33,672
+6
| +0% | +$154 | ﹤0.01% | 1047 |
|
|
2024
Q2 | $433K | Buy |
+33,666
| New | +$433K | ﹤0.01% | 1587 |
|
|
2022
Q4 | – | Sell |
-1,040
| Closed | -$27K | – | 2982 |
|
|
2022
Q3 | $27K | Buy |
+1,040
| New | +$27K | ﹤0.01% | 2736 |
|